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Paramyxovirus fusion proteins have two heptad repeat domains, HR1 and HR2, which have been implicated
in the fusion activity of the protein. Peptides with sequences from these two domains form a six-stranded coiled
coil, with the HR1 sequences forming a central trimer (K. A. Baker, R. E. Dutch, R. A. Lamb, and T. S.
Jardetzky, Mol. Cell 3:309–319, 1999; X. Zhao, M. Singh, V. N. Malashkevich, and P. S. Kim, Proc. Natl. Acad.
Sci. USA 97:14172–14177, 2000). We have extended our previous mutational analysis of the HR1 domain of the
Newcastle disease virus fusion protein, focusing on the role of the amino acids forming the hydrophobic core
of the trimer, amino acids in the “a” and “d” positions of the helix from amino acids 123 to 182. Both
conservative and nonconservative point mutations were characterized for their effects on synthesis, stability,
proteolytic cleavage, and surface expression. Mutant proteins expressed on the cell surface were characterized
for fusion activity by measuring syncytium formation, content mixing, and lipid mixing. We found that all
mutations in the “a” position interfered with proteolytic cleavage and surface expression of the protein,
implicating the HR1 domain in the folding of the F protein. However, mutation of five of seven “d” position
residues had little or no effect on surface expression but, with one exception at residue 175, did interfere to
various extents with the fusion activity of the protein. One of these “d” mutations, at position 154, interfered
with proteolytic cleavage, while the rest of the mutants were cleaved normally. That most “d” position residues
do affect fusion activity argues that a stable HR1 trimer is required for formation of the six-stranded coiled coil
and, therefore, optimal fusion activity. That most of the “d” position mutations do not block folding suggests
that formation of the core trimer may not be required for folding of the prefusion form of the protein. We also
found that mutations within the fusion peptide, at residue 128, can interfere with folding of the protein,
implicating this region in folding of the molecule. No characterized mutation enhanced fusion.
Entry of enveloped viruses into susceptible cells requires
fusion of viral and cellular membranes (12). This fusion is
mediated by viral fusion proteins, which have recognizable
sequence elements important for this activity. One of these
sequences, the fusion peptide, inserts into target or cellular
membranes attaching to these membranes and disordering the
cellular lipid bilayer (12). Viral fusion proteins also often have
heptad repeat regions (7). Results of studies in several systems
indicate that heptad repeat domains are involved in conforma-
tional changes in the protein that take place upon activation of
fusion. These conformational changes are proposed, in part, to
pull viral and cellular membranes in close proximity required
for subsequent fusion events (2, 6, 23). The heptad repeat
domains may also be directly involved in these subsequent
steps (15, 26).
Membrane fusion mediated by paramyxoviruses, such as
Newcastle disease virus (NDV), is mediated by the fusion
protein (F) (reviewed in reference 18). This protein is synthe-
sized as a precursor (F0) which is activated upon proteolytic
cleavage to produce disulfide-linked F1 and F2 polypeptides
(reviewed in reference 18). Cleavage, which places the fusion
peptide or fusion sequence at the new amino terminus of F1
(12), also results in a conformational shift indicated by in-
creased hydrophobicity (14). Immediately adjacent to the fu-
sion peptide is a heptad repeat sequence, heptad repeat 1
(HR1) (7). Mutational analysis of both regions has shown that
both the fusion peptide and adjacent heptad repeat play a role
in the fusion activity of the protein (13, 31). That peptides with
sequences from the HR1 domain interfere with fusion activity
of the intact protein additionally suggests a role of this domain
in fusion (15, 42)
The paramyxovirus F proteins have, adjacent to the trans-
membrane region, HR2 domains, which have also been impli-
cated in the fusion activity. Mutations in these regions abolish
fusion, and peptides with sequences from these domains in-
hibit fusion (4, 11, 19, 27, 28, 39–41). Furthermore, these HR2
peptides interact with peptides from HR1 domains (2, 20, 22,
42), forming a six-stranded structure with a central core trimer
of HR1 peptides with three HR2 peptides bound to the trimer
(2, 20, 43). It is proposed that both HR1 and HR2 peptides
mimic their respective domains in the intact protein interfering
with interactions of the HR1 and HR2 domains necessary for
fusion to proceed (2, 15, 42). The correlate to this hypothesis
is that the two domains do not complex prior to activation of
fusion and are therefore accessible to peptide binding.
These considerations suggest that the F protein is synthe-
sized in a prefusion conformation which changes upon activa-
* Corresponding author. Mailing address: Department of Molecular
Genetics and Microbiology, University of Massachusetts Medical
School, 55 Lake Ave. North, Worcester, MA 01655. Phone: (508)
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tion of fusion. Fusion activation clearly requires cleavage of the
molecule. However, additional shifts may occur with the actual
onset of fusion, analogous to changes detected in retroviral
envelope proteins upon attachment of the SU-TM complex to
receptors (8, 10, 32, 38) or upon acid activation of the influenza
hemagglutinin protein (5, 6). To define properties of the pre-
fusion and postfusion conformations of the NDV F protein, we
have extended our previous mutational analysis of the HR1
domain (31), focusing on residues that form the hydrophobic
core of the HR1 trimer in the peptide complexes (2, 43). We
found that some of these mutations interfere with the proper
folding of the molecule, likely perturbing structures required in
the formation of the prefusion form of the protein. However,
other mutations minimally alter folding and surface expression
but impact the fusion activity of the protein. That mutation of
some core residues had no effect on folding suggests that the
HR1 trimer may not form during folding of F0. We also found
that mutations at residue 154 interfere with the cleavage of the
molecule without perturbing intracellular transport and may
alter the conformation of the cleavage site in the F0 protein.
MATERIALS AND METHODS
Cells, vectors, and viruses. Cos-7 cells, obtained from the American Type
Culture Collection, were maintained in Dulbecco modified Eagle medium
(DMEM) supplemented with nonessential amino acids, vitamins, penicillin and
streptomycin, and 10% fetal calf serum.
NDV HN and F genes were expressed in Cos cells using pSVL (Pharmacia) as
previously described (31).
Site-specific mutagenesis. The F gene mutants were generated with a mu-
tagenesis kit from Amersham Corporation using the appropriate oligomer for
each mutation. Oligomers of 33 to 39 nucleotides were required to successfully
isolate mutants of the fusion peptide and heptad repeat regions of the fusion
protein gene. The entire gene of the mutant DNA was sequenced to verify that
the rest of the gene remained unchanged by the mutagenesis reaction. The
mutations isolated are shown in Fig. 1. Mutation names show the wild-type
amino acid (in single-letter code), the position of the change, and the mutant
amino acid.
Transfections. Transfections using Lipofectin or Lipofectamine (BRL/Gibco)
were done as recommended by the manufacturer. Cos cells were plated at 3 3
105 per 35-mm plate and transfected 20 to 24 h later. For each 35-mm plate, a
mix of DNA in 0.1 ml of OptiMem (BRL/Gibco) and 10 ml of transfection
reagent in 0.2 ml of OptiMem was incubated at room temperature for 45 min and
then diluted with 0.7 ml of OptiMem and added to a plate previously washed with
OptiMem. Cells were incubated for 5 h, and then 2 ml of Cos cell medium was
added.
Antibodies. Antibodies used were anti-Ftail, anti-Fu1a, and anti-NDV. Anti-
Ftail antibody was raised against a synthetic peptide with the sequence of the
cytoplasmic tail of the fusion protein as described by Wang et al. (37) and
prepared by the Peptide Core Facility of the University of Massachusetts Med-
ical School. Anti-Fu1a is a monoclonal antibody obtained from Mark Peeples
(30). Anti-NDV is a polyclonal antiserum raised in rabbits against UV-inacti-
vated virions as previously described (30).
Immunofluorescence. Cos cells were plated on 35-mm plates containing glass
coverslips (Corning) and transfected as described above. The cells were washed
twice with phosphate-buffered saline (PBS) and incubated at 4°C in PBS con-
taining 3% bovine serum albumin (BSA), 0.02% sodium azide, and antibody
(anti-NDV) for 1 h. Cells were washed three times with PBS containing BSA and
azide and incubated with ice-cold PBS containing BSA, azide, and anti-rabbit
immunoglobulin G (IgG) coupled to Alexa dye 488 (Molecular Probes) for 1 h.
Cells were washed in ice-cold PBS containing azide and BSA. Pictures of the cells
were taken immediately.
Flow cytometry. Transfected cells were removed from plates with cell detach-
ment buffer (Sigma Co.) after a 1-min pulse in trypsin (5 mg/ml), washed in PBS
containing 1% BSA and 0.02% azide (fluorescence-activated cell sorting [FACS]
buffer), and incubated with anti-NDV antibody for 1 h at 4°C. After three washes
with FACS buffer, cells were incubated for 1 h at 4°C with goat anti-rabbit IgG
coupled to Alexa dye 488. After three washes in FACS buffer, cells were resus-
pended in PBS containing 2% paraformaldehyde and subjected to flow cytometry
(University of Massachusetts Medical School Flow Cytometry Facility). Cells
transfected with vector alone and incubated with both primary and secondary
antibody were used as controls.
Western analysis of mutant proteins. Cell extracts were diluted in sample
buffer and loaded onto 10% polyacrylamide gels without boiling. After electro-
phoresis, the gels were subsequently equilibrated in transfer buffer (25 mM Tris,
192 mM glycine, 5% methanol [pH 8.2]) and transferred to Immobilon-P (Mil-
FIG. 1. Location of mutations. The sequence of the amino terminus of the F1 protein including both the fusion peptide and HR1 is shown.
The overlapping dashed lines indicate that the boundary of the two domains is unclear. The positions of the hydrophobic residues in the heptad
repeat of the HR1 domain are indicted by “a” and “d” above the sequence. Small arrows indicate the positions of mutations previously reported
and partially characterized (31), and bold arrows indicate the new mutations described here. Upward and downward arrows indicate mutations that
do not block surface expression and those that do block surface expression, respectively.
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lipore Corp.) membranes. The membrane was blocked in PBS containing 0.5%
Tween 20 and 10% nonfat dried milk for 2 h at room temperature or overnight
at 4°C. Membranes were washed in PBS-Tween 20 and incubated with primary
antibody diluted in PBS-Tween 20 and 0.5% nonfat milk for 2 h at room
temperature. Membranes were washed and then incubated in secondary anti-
body, anti-rabbit IgG coupled to horseradish peroxidase (Boehringer Mann-
heim) diluted in PBS-Tween and 0.5% nonfat milk, for 1 h at room temperature.
Membranes were washed extensively, and bound antibody was detected using the
ECL Western blotting detection reagent system (Amersham).
Radiolabeling and immunoprecipitation of protein. Transfected cells were
radiolabeled for 2 to 4 h at 37°C in DMEM lacking methionine but containing
100 mCi of [35S]methionine (Amersham) per ml. At the end of the labeling
period, cells were washed in PBS and lysed in RSB buffer (0.01 M Tris-HCl [pH
7.4], 0.01 M NaCl) containing 1% Triton X-100, 0.5% sodium deoxycholate, 2 mg
of iodoacetamide/ml, and 0.2 mg of DNase/ml as previously described (13, 14,
20). Immunoprecipitation of NDV proteins was accomplished as previously
described (30).
Sucrose gradients. At 48 h posttransfection, cells were lysed in RSB buffer, 1%
Triton X-100, and 10 mM iodoacetamide and layered on top of 10-to-45%
continuous sucrose gradients made in RSB buffer containing 0.1% Triton X-100.
Gradients were spun in an SW41 rotor for 18 h at 38,000 rpm at 17°C and
collected into 16 equal fractions. Proteins present were precipitated with trichlo-
roacetic acid and resolved on polyacrylamide gels for Western analysis. Marker
proteins used were ferritin (450 kDa), catalase (240 kDa), aldolase (158 kDa),
and BSA (68 kDa) (Boehringer). The locations of the marker proteins in the
gradients were determined by Coomassie blue staining of the gradient fractions.
Fusion assays. (i) Syncytium formation. Cos cells were cotransfected with
wild-type or mutant fusion protein genes and the wild-type HN protein gene
using Lipofectin. At 24 and 48 h posttransfection, the numbers of nuclei in 40
fusion areas were counted to determine the average size of syncytia at each time
point as previously described (30). Values obtained after transfection of the
vector alone were subtracted.
(ii) Content mixing. To measure content mixing, a plasmid encoding a tetra-
cycline (TET)-responsive transcriptional activator, pTet-Off (Clontech), was
transfected along with HN and F cDNAs. A separate population of cells was
transfected with pTRE2 (Clontech) with a b-galactosidase gene inserted into the
cloning cassette. This plasmid contains a TET-responsive element upstream from
a cytomegalovirus promoter. After 30 h, Cos cells transfected with the b-galac-
tosidase gene were trypsinized and then plated on Cos cells expressing HN and
F protein as well as the TET-responsive transactivator. At 45 h posttransfection,
when fusion was evident, the monolayers were lysed and extracts were assayed
for b-galactosidase activity. Activity due to background fusion typical of Cos cells
was measured after transfecting cells with comparable amounts of vector alone,
and values obtained were subtracted from values obtained with cells expressing
HN and wild-type F or mutant F proteins.
(iii) Lipid mixing. The lipid mixing protocol used was similar to that previously
described (16, 17). Avian red blood cells (RBC) (Crane Laboratories) were
washed in PBS, resuspended in PBS, and incubated with 15 mg of R18 (Molec-
ular Probes)/ml for 30 min at room temperature in the dark. Complete medium
(3 volumes of DMEM with 10% fetal calf serum) was added, and incubation was
continued for 30 min. The RBC were washed four times in ice-cold PBS, resus-
pended in PBS containing CaCl2, and added to transfected cells that had been
washed in PBS with CaCl2. Cells were incubated for 1 h at 37°C, washed in cold
PBS containing CaCl2, and visualized using a Nikon fluorescence microscope.
RESULTS
Mutagenesis of the amino terminus of F1. Figure 1 shows
the amino acid sequence of the amino terminus of the NDV F1
protein, including mutations previously made in this region
(31) and new mutations described here. Mutations previously
made in the heptad repeat region of the NDV F protein sub-
stituted charged residues for hydrophobic or polar amino acids
and resulted in either transit-competent but fusion-negative
proteins or proteins that were not properly folded (31). New
mutations N147A and L154A introduced the uncharged amino
acid alanine into two of these positions to determine if the
introduction of a charge into these positions was responsible
for the fusion-negative phenotype of the original set of mu-
tants. In addition, mutations T161K, T161A, V168K, L175K,
V179K, and M182K were made to define the role of these core
amino acids in the HR1 domain.
Two new mutations were also made in the fusion peptide
region, G123A and G128A. Previous mutation of these resi-
dues substituted lysine and leucine residues, respectively, into
these positions, resulting in defective proteins. The G123K
mutant, while expressed at the cell surface, was fusion nega-
tive. The G128L mutant failed to fold properly. In the very
similar simian virus 5 (SV5) fusion protein, these residues have
been changed individually to alanines, resulting in mutant pro-
teins with enhanced fusion activity (13). Thus, these residues
were changed to alanines to determine if the resulting NDV
fusion proteins also had enhanced fusion activity.
Expression of mutant proteins. The mutant proteins were
expressed in Cos-7 cells using a simian virus 40-based vector
and radioactively labeled with [35S]methionine for 2 h at 48 h
posttransfection as previously described (29–31). The labeled
proteins, precipitated with polyclonal antibody raised against a
peptide with the sequence of the cytoplasmic tail (37), were
electrophoresed in the presence (Fig. 2A) or absence (Fig. 2B)
of reducing agent. In the presence of reducing agent, F0 and F1
were resolved and F2 was not detected (31). In the absence of
reducing agent, the uncleaved F0 and the cleaved but disulfide-
linked F1 and F2 comigrated as a single band with an approx-
imate molecular weight of 66,000 (Fnr).
Under reducing conditions, all mutant proteins were re-
solved and levels of expression were similar to the that of
wild-type protein. The G128A, L154A, V168K, and V179K
(Fig. 2A) and M182K (Fig. 2D) mutant DNAs expressed pri-
marily the uncleaved fusion protein, F0, while cleavage of
G123A, N147A, T161K, T161A, and L175K proteins was com-
parable to that of wild-type protein. In the absence of reducing
agent, all mutant proteins were resolved, although very small
amounts of uncleaved mutant proteins, G128A, L154K,
V168K, V179K (Fig. 2B), and M182K (Fig. 2D), were de-
tected. Decreased detection of these mutant proteins in the
absence of reducing agent suggested that these proteins form
disulfide linked aggregates that failed to enter the gel, a finding
that suggests abnormal folding (3, 33).
The total amounts of cell-associated mutant proteins relative
to wild-type protein were assessed by Western analysis (Fig. 2C
and D). All mutant proteins were detected at levels compara-
ble to those of the wild type.
Surface expression of mutant proteins. To determine which
mutant proteins were transported to the cell surface, cell sur-
face F protein was detected by immunofluorescence as previ-
ously described (31) (Fig. 3). The results were confirmed and
quantitated by flow cytometry (Fig. 4 and 5). Cells were trans-
fected with suboptimal levels of DNA in order to avoid effects
due to overexpression of viral proteins. Figure 4 shows the
percent positive cells detected relative to cells transfected with
wild-type DNA. Figure 5 shows the intensity of surface expres-
sion for mutants detected at the surface. All mutant proteins
that were cleaved could be detected at the cell surface (Fig. 3)
and were expressed at densities comparable to that of the
wild-type protein (Fig. 4 and 5). In addition, the L154A mutant
was also expressed at the cell surface. However, the V168K,
V179K, and M182K mutants were minimally detected at cell
surfaces, and surface expression of the G128A protein was
considerably reduced.
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Sucrose gradient analysis of mutant proteins. To character-
ize the oligomeric structure of the mutant proteins, the sedi-
mentation properties of mutant proteins were compared to
those of the wild-type protein on 10-to-45% sucrose gradients
as previously described (28). The proteins in each gradient
fraction were detected by Western analysis using antibody
raised against the cytoplasmic tail sequences. All mutants were
characterized, and representative results are shown in Fig. 6.
As previously reported (28), wild-type protein sedimented
slightly faster than the marker protein aldolase (158 kDa) but
slightly slower than catalase (240 kDa), a behavior consistent
with a trimer (Fig. 6A). Figure 6B shows sedimentation char-
acteristic of mutant proteins that were cleaved and surface
expressed but fusion defective. These proteins sedimented as
the wild-type protein, although some of the F0 sedimented in
larger, more heterogeneously sized material. Figure 6C shows
results characteristic of uncleaved mutants that were not ex-
pressed at the surface. These proteins sedimented very heter-
ogeneously, and most of the protein formed very large heter-
ogeneous material. The majority of the minimally cleaved 154-
kDa protein sedimented as wild-type protein, although some
material was also larger (Fig. 6D).
FIG. 2. Characterization of mutant F proteins. (A and B) Precipitation of radiolabeled F proteins synthesized in cells transfected with plasmids
encoding mutant F proteins (indicated above each lane). Cells transfected with 0.5 mg of DNA/35-mm plate of Cos cells were labeled with
[35S]methionine for 2 h at 48 h posttransfection and subjected to a 4-h chase. Equivalent amounts of protein present in extracts (from 2 3 105 cells)
were precipitated with anti-Ftail antibody, and the precipitated proteins were resolved on polyacrylamide gels in the absence (A) or presence (B)
of reducing agent after boiling in sample buffer. (C and D) Western analysis of proteins present in 5 3 105 cells at 48 h posttransfection. Samples
were not boiled prior to loading on polyacrylamide gels. Anti-Ftail was used to detect F protein. Fwt, wild-type F protein; M, marker proteins from
infected cell extracts; V, vector.
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Fusion activities of mutant proteins. The fusion activities of
mutant proteins were determined by measuring syncytium for-
mation, content mixing, and hemifusion. Syncytium formation
directed by these mutant proteins was quantitated by syncy-
tium size, as previously described (31), and the results are
shown in Table 1. As expected, mutant proteins minimally
detected at the cell surface (G128A, V168A, V179K, and
M182K) did not direct syncytium formation, nor did the un-
cleaved L154A protein. However, G123A, N147A, T161A, and
T161K mutants, which were found at the cell surface and
proteolytically cleaved, had negligible syncytium-forming activ-
ity, results very similar to those obtained with G123K and
N147K proteins (31). In contrast, L175K protein formed syn-
cytia at nearly wild-type levels.
Content-mixing activities of these mutants were measured in
a protocol similar, in principle, to previously reported proto-
cols (25). Cells were transfected with a plasmid carrying the
b-galactosidase gene driven by a promoter responsive to a
TET-sensitive transactivator. These cells were mixed with cells
transfected with plasmid DNAs containing HN and F genes as
well as a plasmid encoding the TET-responsive transactivator
of transcription. b-Galactosidase synthesis should be induced
only when cells from the different populations fused. Indeed,
significant activity was detected when both F and HN cDNAs
were present (Fig. 7A). However, little enzyme activity was
present when only F cDNA or only HN cDNA was present.
Furthermore, there was little activity after transfection with
HN cDNA and an F cDNA that encodes an uncleaved F
protein (F115G) (21) (Fig. 7A). This assay is also dependent
on the levels of expression of HN and F proteins, since there
was a linear increase of activity as the amounts of DNA used
were increased (24).
Content mixing directed by each of the F protein mutants in
the presence of wild-type HN cDNA is shown in Fig. 7B. We
have previously described other transport-competent muta-
tions in this region (Fig. 1) which block syncytium formation
(31). To determine their effects on content mixing as well as to
compare effects of conservative and nonconservative mutations
at similar positions, the content mixing directed by these mu-
tant proteins was also determined. It is clear that the closer the
mutation is to the amino terminus of F1, the greater the inhi-
bition of content mixing. Furthermore, mutant proteins with
FIG. 3. Immunofluorescence of cell surfaces expressing mutant proteins. Cells were transfected with 0.5 mg of DNA/35-mm plate of Cos cells
and prepared for immunofluorescence as described in Materials and Methods. Pictures are of 4-s exposures of Kodak TMAXp3200 film using a
Nikon inverted fluorescent microscope. Fwt, wild-type F protein.
FIG. 4. Percent positive cells detected by flow cytometry analysis
relative to wild type (Fwt; set at 100%) determined from data shown in
Fig. 5 as well as duplicate experiments. The percentage of transfected
Cos-7 cells expressing the wild-type F protein was 20% in the experi-
ment shown.
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alanines in positions 147 and 123 allowed more content mixing
than mutant proteins with lysines at the same positions. The
residue at position 161, however, made little difference in the
activity of the protein.
To determine if mutants which did not direct content mixing
were capable of mediating lipid mixing, RBC fluorescently
labeled with R18 were incubated with cells expressing these
mutant proteins as previously described (16, 17). Figure 8
shows representative results. As expected, cells expressing the
HN protein bound RBC, but there was no transfer of fluores-
cence from the RBC to the cells. In contrast, cells expressing
both HN and F proteins became fluorescent as a result of the
dye transfer. Not unexpectedly, cells expressing the HN pro-
tein as well as proteins with mutations in the fusion peptide
(G119K and A130K) showed no evidence of lipid mixing. Fur-
thermore, cells expressing HN protein as well as A140K or
N147K protein showed little or no lipid mixing. Thus, these
more amino-terminal mutations inhibit fusion at the earliest
stages.
DISCUSSION
Mutational analysis of the HR1 domain. The published
structure of a peptide with the SV5 HR1 sequence indicates
that the region comparable to the NDV F protein from amino
acids 136 to 199 has the potential to form a trimer (2). We have
focused our present and previous mutational analyses on the
hydrophobic or polar amino acids that form the interior of this
trimer structure from amino acid 130 to 182 in order to deter-
mine the effect formation of this trimer may have on folding as
well as fusion activity. The crystal structure of the NDV F
protein was recently published (9), and the HR1 domain from
amino acid 171 to 221 forms a trimer in this structure. How-
ever, the amino terminus of F1, from amino acid 117 to 170,
was missing from the structure, and therefore the conforma-
tion of this region is unclear.
The trimer hydrophobic core in the SV5 peptide structure is
formed by the “a” and “d” hydrophobic residues in the a helix
formed by an HR1 monomer (2). In this study, we chose to
FIG. 5. Flow cytometry analysis of mutant-expressing cells. Cells transfected with 0.5 mg of DNA/35-mm plate (suboptimal levels) were
processed for analysis by flow cytometry as described in Materials and Methods. Only data for mutant proteins expressed at the surface are shown.
The primary antibody was anti-NDV. Each panel shows background (cells transfected with vector alone) and wild-type data (Fwt) as well as data
for one mutant.
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replace hydrophobic or polar residues nonconservatively with
the charged residue lysine, which can be incorporated into a
monomer helix without its disruption (34). Some “d” residues
were also replaced with alanine to assess differences between
properties of proteins with conservative and nonconservative
changes at the same position. Rather than giving rise to similar
phenotypes, mutations of the core residues fall into four cat-
egories: mutations that block surface expression, mutations
that allow surface expression and cleavage but inhibit fusion
activity, mutations that allow surface expression but block pro-
teolytic cleavage, and mutations at a single residue that have
no effect on surface expression or fusion activity.
Recent studies of model peptides that form trimers have
investigated the effect of different amino acids inserted into a
central single site in either the “a” or “d” position (34–36).
These experiments have shown that a single lysine residue in
either an “a” or “d” position results in exclusively dimer for-
mation. This result has been attributed to the significantly
increased difficulty in burying the charge within the hydropho-
bic core of a trimer as opposed to a dimer. Substitution of an
alanine in either an “a” or “d” position favors dimer formation
but results in a mixed population of approximately 60% dimers
and 30% trimers.
Studies with model peptides suggest that substitution of ly-
sine at either “a” or “d” positions in the HR1 domain should
have a similar disrupting effect on formation of the core trimer
structure (34–36). If the core trimer must form during folding,
then lysine residues in either “a” or “d” positions should block
surface expression. While lysine residues in all “a” positions
characterized were defective in folding, as determined by the
expression of the protein at the cell surface and cleavage, five
of seven “d” position substitutions had little detectable effect
on folding and surface expression. That most of the “d” posi-
tion substitutions allow cleavage and surface expression sug-
gests that formation of an HR1 trimer characterized in peptide
studies may not be absolutely required for F0 folding. Perhaps
“a” position residues participate in a structure necessary for
formation of the prefusion, precleavage form of the protein
that is different than the core HR1 trimer defined by peptide
studies. It follows, then, that formation of the core HR1 trimer
may occur only upon proteolytic cleavage or activation of fu-
sion.
While the role of “a” position residues in fusion cannot be
assessed because of the absence of surface expression of these
mutant proteins, all surface-expressed mutants with “d” posi-
tion residues altered to lysine, with the exception of one with a
mutation at amino acid 175, did not direct fusion. That most
“d” position residues do affect fusion activity argues, not sur-
prisingly, that a stable HR1 trimer is required for optimal
fusion activity. The substitution of alanine also inhibited fu-
sion, although not as stringently as the lysine substitutions, as
might be expected since alanine should only decrease the fre-
quency of trimer formation in the population (34) and should
FIG. 6. Sucrose gradient analysis of mutant proteins. At 48 h post-
transfection, cells were lysed and extracts were layered onto a 10-to-
45% sucrose gradient as described in Materials and Methods. Proteins
present in each fraction were precipitated with trichloroacetic acid,
incubated at 50°C for 10 min, and electrophoresed in the presence of
reducing agent, and the F protein in each fraction was detected by
Western analysis. Virion proteins (M) were electrophoresed in the last
lane of each polyacrylamide gel and are shown in panels A to C. F0
migrates slightly slower than the marker F1. F, ferritin; C, catalase; A,
aldolase; B, BSA; Fwt, wild type.
TABLE 1. Syncytium formation by mutant proteins
DNA
Size of syncytia ata:
% of wild typeb
48 h 72 h
Wild type 16 6 2 21 6 4 100
G123A 0.2 6 0.2 0.4 6 0.3 1.9
G128A 0.5 6 0.2 0.4 6 0.1 1.9
N147A 0.6 6 0.2 0.5 6 0.5 2.3
L154A 0.6 6 0.2 0.1 6 0.1 0.4
T161K 1.0 6 0.7 0.4 6 0.4 1.9
T161A 1.1 6 1.0 0.4 6 0.4 1.9
V168A 0.5 6 0.2 0.25 6 0.25 1.1
L175K 8 6 3 17.4 6 2 82.8
V179K 0.6 6 0.5 0.1 6 0.1 0.4
M182K 0.3 6 0.1 0.6 6 0.4 2
a The average numbers of nuclei at 48 and 72 h posttransfection are shown.
The background values obtained after transfection of the vector alone into Cos
cells were subtracted, and the numbers are the averages of at least three separate
determinations. The actual variation between all experiments is also shown.
b The percentage of the wild-type value was calculated using the 72-h time
points.
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have a less destabilizing effect than lysine (34). Interestingly,
fusion inhibition by these mutants was more stringent the
closer the mutations were to the amino terminus of F1. This
result may indicate that stability of the core timer at its amino-
terminal end may be more critical to the formation of a func-
tional HR1-HR2 complex.
The third phenotype of HR1 mutations was that of L154A
mutant protein. This mutation, in a “d” position, had little
detectable effect on folding of F0. Expression at the surface was
comparable to that of the wild-type protein, yet this protein
remained uncleaved. We have previously reported that substi-
tution of lysine at this position had an identical effect on the
protein (31). In addition, L154K mutant protein reacted to a
conformationally sensitive monoclonal antibody (31), also in-
dicating no gross conformational abnormalities. These results
suggest that mutation at this site in the HR1 sequence alters
the conformation or accessibility of the cleavage site region of
the molecule, rendering it resistant to host cell proteases. Since
this region of the F protein was missing in the crystal structure
(9), the effect of this residue on the cleavage site is unknown.
A surprising finding was that one mutation, a change of a
leucine to a lysine residue at position 175, had no apparent
effect on folding or fusion. This residue is at the amino termi-
nus of the region visualized in the F protein crystal structure
(9) and forms part of the core of the trimer resolved in the
structure, a trimer that extends from amino acid 171 to 221.
However, if this residue is at the boundary of the trimer, then
mutations may have minimal effects on folding, in contrast to
mutations at residues 179 and 182, which fall within the trimer
and do block folding. Chen et al. (9) proposed that upon fusion
activation, the entire HR1 domain forms an extended trimer
similar to the SV5 peptide structure. In such a structure, res-
idue 175 would be in the middle of the extended trimer. The
mutation at residue 175 may not affect fusion because, as
suggested above, the stability of the amino-terminal end of the
trimer may be more important for fusion than stability of more
carboxyl-terminal regions.
Mutational analysis of the fusion peptide. Here we describe
two mutants with changes in the fusion peptide sequence,
G123A and G128A. We have previously reported properties of
mutants with nonconservative changes of these residues (31).
G123K allowed surface expression but not fusion, while G128L
blocked surface expression. However, conservative changes at
the same residues in the very similar SV5 F protein actually
enhanced fusion (13). A conservative G-to-A change at amino
acid 123 in the NDV F sequence, however, still resulted in a
fusion-defective protein. A conservative G-to-A change at po-
sition 128 still resulted in a folding-defective protein, although
the surface expression of this mutant was slightly increased
over that of the protein with the G-to-L change previously
FIG. 7. Fusion activity of mutant proteins measured by content mixing. The extent of content mixing of all mutants was measured as described
in Materials and Methods and is expressed as a percentage of that observed for wild-type F protein (Fwt). (A) Control experiments. F-K115G is
a cleavage mutant of F protein (21). (B) Content mixing of fusion peptide and HR1 mutants. The results are the averages of three separate
experiments.
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reported. These observations are interesting in two ways. First,
the different phenotypes of similar mutants in the SV5 and
NDV fusion proteins underscore the differences between these
two proteins, the most significant of which is the difference in
requirement of HN protein for fusion (1). Second, that a mu-
tation in the fusion peptide interferes with surface expression
argues that this domain participates in a conformation critical
to the overall folding of the molecule. However, no mutations
in a potential “a” or “d” position, relative to the HR1 domain,
influenced the folding of the molecule.
In summary, mutational analysis of hydrophobic core resi-
dues in the HR1 trimer suggests that the amino-terminal half
of the HR1 core trimer may not form during folding of the F
protein but may form only upon conformational shifts in the
molecule upon cleavage or initiation of fusion.
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